- Home
- NKTR vs IHD Comparison
NKTR vs IHD Comparison
Compare NKTR & IHD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NKTR
- IHD
- Stock Information
- Founded
- NKTR 1990
- IHD 2011
- Country
- NKTR United States
- IHD United States
- Employees
- NKTR N/A
- IHD N/A
- Industry
- NKTR Biotechnology: Pharmaceutical Preparations
- IHD Investment Managers
- Sector
- NKTR Health Care
- IHD Finance
- Exchange
- NKTR Nasdaq
- IHD Nasdaq
- Market Cap
- NKTR 108.3M
- IHD 94.9M
- IPO Year
- NKTR 1994
- IHD N/A
- Fundamental
- Price
- NKTR $24.73
- IHD $5.87
- Analyst Decision
- NKTR Strong Buy
- IHD
- Analyst Count
- NKTR 6
- IHD 0
- Target Price
- NKTR $81.67
- IHD N/A
- AVG Volume (30 Days)
- NKTR 4.9M
- IHD 27.7K
- Earning Date
- NKTR 08-07-2025
- IHD 01-01-0001
- Dividend Yield
- NKTR N/A
- IHD 10.32%
- EPS Growth
- NKTR N/A
- IHD N/A
- EPS
- NKTR N/A
- IHD N/A
- Revenue
- NKTR $87,248,000.00
- IHD N/A
- Revenue This Year
- NKTR N/A
- IHD N/A
- Revenue Next Year
- NKTR N/A
- IHD N/A
- P/E Ratio
- NKTR N/A
- IHD N/A
- Revenue Growth
- NKTR N/A
- IHD N/A
- 52 Week Low
- NKTR $6.48
- IHD $4.49
- 52 Week High
- NKTR $37.38
- IHD $5.47
- Technical
- Relative Strength Index (RSI)
- NKTR 67.01
- IHD 56.83
- Support Level
- NKTR $21.87
- IHD $5.81
- Resistance Level
- NKTR $26.89
- IHD $5.92
- Average True Range (ATR)
- NKTR 2.11
- IHD 0.06
- MACD
- NKTR -0.20
- IHD -0.02
- Stochastic Oscillator
- NKTR 76.31
- IHD 46.35
About NKTR Nektar Therapeutics
Nektar Therapeutics is a clinical-stage, research-based drug discovery biopharmaceutical company focused on discovering and developing medicines in the field of immunotherapy. The company is focused on discovering and developing medicines in the field of immunotherapy. Its pipeline products are REZPEG (NKTR-358), REZPEG (NKTR-358), REZPEG (NKTR-358), NKTR-422, NKTR-0165, NKTR-255, and Others.
About IHD Voya Emerging Markets High Income Dividend Equity Fund
Voya Emerging Markets High Dividend Equity Fund is a diversified closed-end management investment company. Its primary investment objective is to provide total return through a combination of current income, capital gains, and capital appreciation. The company seeks to achieve its investment objectives by investing principally in a portfolio of equity securities, and issuers in emerging market countries. The Fund will also normally seek to secure gains and enhance the stability of returns over a market cycle by writing (selling) call options on selected exchange-traded funds (ETFs) and/or international, regional, or country indices of equity securities, and/or on equity securities.